Literature DB >> 10557608

Laxative drug products for over-the-counter human use. Food and Drug Administration, HHS. Final rule.

.   

Abstract

The Food and Drug Administration (FDA) is issuing a final rule establishing that the over-the-counter (OTC) stimulant laxative ingredients danthron and phenolphthalein are not generally recognized as safe and effective and are misbranded. FDA is issuing this final rule as part of its ongoing review of OTC drug products after considering data and information on the safety of danthron and phenolphthalein.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10557608

Source DB:  PubMed          Journal:  Fed Regist        ISSN: 0097-6326


  2 in total

Review 1.  Evolution of 3-(4-hydroxyphenyl)indoline-2-one as a scaffold for potent and selective anticancer activity.

Authors:  Matthew W Boudreau; Paul J Hergenrother
Journal:  RSC Med Chem       Date:  2022-05-09

2.  Toxicology and carcinogenesis study of senna in C3B6.129F1-Trp53 tm1Brd N12 haploinsufficient mice.

Authors:  Inok Surh; Amy Brix; John E French; Bradley J Collins; J Michael Sanders; Molly Vallant; June K Dunnick
Journal:  Toxicol Pathol       Date:  2012-11-02       Impact factor: 1.902

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.